» Articles » PMID: 12086981

Inhibition of the Current of Heterologously Expressed HERG Potassium Channels by Flecainide and Comparison with Quinidine, Propafenone and Lignocaine

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2002 Jun 28
PMID 12086981
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

1. The inhibition of the cardiac 'rapid' delayed rectifier current (I(Kr)) and its cloned equivalent HERG mediate QT interval prolonging effects of a wide range of clinically used drugs. In this study, we investigated the effects of the Class Ic antiarrhythmic agent flecainide (FLEC) on ionic current (I(HERG)) mediated by cloned HERG channels at 37 degrees C. We also compared the inhibitory potency of FLEC with other Class I agents: quinidine (QUIN, Class Ia); lignocaine (LIG, Class Ib) and propafenone (PROPAF, Class Ic). 2. Whole cell voltage clamp recordings of I(HERG) were made from an HEK293 cell line stably expressing HERG. FLEC inhibited I(HERG) 'tails' following test pulses to +30 mV with an IC(50) of 3.91+/-0.68 microM (mean+/-s.e.mean) and a Hill co-efficient close to 1 (0.76+/-0.09). 3. In experiments in which I(HERG) tails were monitored following voltage commands to a range of test potentials, I(HERG) inhibition by FLEC was observed to be voltage-dependent and to be associated with a approximately -5 mV shift of the activation curve for the current. Voltage-dependence of inhibition was greatest over the range of potentials corresponding to the steep portion of the I(HERG) activation curve. The time-course of I(HERG) tail deactivation was not significantly altered by FLEC. 4. In experiments in which 10 s depolarizing pulses were applied from -80 to 0 mV, the level of current inhibition by FLEC did not increase between 1 and 10 s. Some time-dependence of inhibition was observed during the first 200 - 300 ms of depolarization. This observation and the voltage-dependence of inhibition are collectively consistent with FLEC exerting a rapid open channel state inhibition of I(HERG). 5. Under similar recording conditions QUIN inhibited I(HERG) with an IC(50) of 0.41+/-0.04 microM and PROPAF inhibited I(HERG) with an IC(50) of 0.44+/-0.07 microM. Similar to FLEC, both QUIN and PROPAF showed voltage-dependence of inhibition and blockade developed rapidly during a sustained depolarization. 6. LIG showed little effect on I(HERG) at low micromolar concentrations, but could inhibit the current at higher concentrations; the observed IC(50) was 262.90+/-22.40 microM. 7. Our data are consistent with FLEC, PROPAF and QUIN exerting I(HERG) blockade at clinically relevant concentrations. The rank potency as HERG blockers of the Class I drugs tested in this study was QUIN=PROPAF>FLEC>>LIG.

Citing Articles

Kir2.1 mutations differentially increase the risk of flecainide proarrhythmia in Andersen Tawil Syndrome.

Cruz F, Moreno-Manuel A, Perez P, Ruiz-Robles J, Socuellamos P, Gutierrez L medRxiv. 2024; .

PMID: 39711719 PMC: 11661358. DOI: 10.1101/2024.12.10.24318629.


KCNT1 Channel Blockers: A Medicinal Chemistry Perspective.

Di Matteo F, Mancuso F, Turcio R, Ciaglia T, Stagno C, Di Chio C Molecules. 2024; 29(12).

PMID: 38931004 PMC: 11206332. DOI: 10.3390/molecules29122940.


Assisted Identification, Synthesis, and Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel.

Iraci N, Carotenuto L, Ciaglia T, Belperio G, Di Matteo F, Mosca I J Med Chem. 2024; 67(11):9124-9149.

PMID: 38782404 PMC: 11181338. DOI: 10.1021/acs.jmedchem.4c00268.


Harnessing AlphaFold to reveal hERG channel conformational state secrets.

Ngo K, Yang P, Yarov-Yarovoy V, Clancy C, Vorobyov I bioRxiv. 2024; .

PMID: 38352360 PMC: 10862728. DOI: 10.1101/2024.01.27.577468.


Drosophila expressing mutant human KCNT1 transgenes make an effective tool for targeted drug screening in a whole animal model of KCNT1-epilepsy.

Hussain R, Lim C, Shaukat Z, Islam A, Caseley E, Lippiat J Sci Rep. 2024; 14(1):3357.

PMID: 38336906 PMC: 10858247. DOI: 10.1038/s41598-024-53588-x.


References
1.
Viskin S . Long QT syndromes and torsade de pointes. Lancet. 1999; 354(9190):1625-33. DOI: 10.1016/S0140-6736(99)02107-8. View

2.
Scamps F, Undrovinas A, Vassort G . Inhibition of ICa in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin. Am J Physiol. 1989; 256(3 Pt 1):C549-59. DOI: 10.1152/ajpcell.1989.256.3.C549. View

3.
Mitcheson J, Hancox J . An investigation of the role played by the E-4031-sensitive (rapid delayed rectifier) potassium current in isolated rabbit atrioventricular nodal and ventricular myocytes. Pflugers Arch. 1999; 438(6):843-50. DOI: 10.1007/s004249900118. View

4.
Lees-Miller J, Duan Y, Teng G, Duff H . Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites. Mol Pharmacol. 2000; 57(2):367-74. View

5.
Mitcheson J, Chen J, Sanguinetti M . Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. J Gen Physiol. 2000; 115(3):229-40. PMC: 2217217. DOI: 10.1085/jgp.115.3.229. View